Page last updated: 2024-08-16

rivastigmine and Hallucination of Body Sensation

rivastigmine has been researched along with Hallucination of Body Sensation in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (44.44)29.6817
2010's7 (38.89)24.3611
2020's3 (16.67)2.80

Authors

AuthorsStudies
Begemann, MJH; d'Angremont, E; Sommer, IEC; van Laar, T1
Beireis, LA; Burgett, RN; Farley, TM1
Breuning, L; Dautzenberg, PLJ1
Bloem, BR; de Bie, RMA; de Haan, RJ; Foncke, EMJ; Munts, AG; Post, B; Schmand, BA; Tissingh, G; van Harten, B; van Mierlo, TJM1
Bonnet, U; Knierim, U; Stuehler, L; Taha, S1
Demirci, S; Hanoglu, L; Polat, B; Tavli, AM; Yildiz, S; Yilmaz, N; Yulug, B1
Aarsland, D; Cummings, J; Dronamraju, N; Emre, M; Lane, R; Tekin, S1
Attard, A; Jacobsen, P; Patel, SS; Shergill, S2
Bedouch, P; Besson, G; Casez, O; Chapuis, C; Lagrange, E1
Bullock, R; Cameron, A1
Retz, W; Retz-Junginger, P; Rösler, M; Supprian, T; Wobrock, T1
Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA1
Kaufer, DI1
Dautzenberg, PL; Rovers, JM; ter Bruggen, JP1
Aarsland, D; Burn, D; De Deyn, PP; Emre, M; Hsu, C; Lane, R; McKeith, I1
Cummings, JL; Emre, M; Lane, RM1
Luce, AK; McKeith, IG; Reading, PJ1

Reviews

3 review(s) available for rivastigmine and Hallucination of Body Sensation

ArticleYear
Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis.
    JAMA neurology, 2023, 08-01, Volume: 80, Issue:8

    Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Female; Hallucinations; Humans; Male; Parkinson Disease; Randomized Controlled Trials as Topic; Rivastigmine

2023
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature.
    BMC psychiatry, 2010, Sep-07, Volume: 10

    Topics: Cholinesterase Inhibitors; Donepezil; Galantamine; Hallucinations; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

2010
Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.
    Journal of Alzheimer's disease : JAD, 2007, Volume: 11, Issue:4

    Topics: Activities of Daily Living; Alzheimer Disease; Double-Blind Method; Hallucinations; Humans; Lewy Body Disease; Mental Status Schedule; Multicenter Studies as Topic; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome

2007

Trials

5 trial(s) available for rivastigmine and Hallucination of Body Sensation

ArticleYear
Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow-up.
    Brain and behavior, 2021, Volume: 11, Issue:8

    Topics: Cholinesterase Inhibitors; Follow-Up Studies; Hallucinations; Humans; Parkinson Disease; Phenylcarbamates; Rivastigmine

2021
Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations.
    Journal of Alzheimer's disease : JAD, 2010, Volume: 20, Issue:1

    Topics: Activities of Daily Living; Aged; Alzheimer Disease; Analysis of Variance; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Hallucinations; Humans; Male; Mental Status Schedule; Neuroprotective Agents; Phenylcarbamates; Placebo Effect; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome

2010
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
    Dementia and geriatric cognitive disorders, 2004, Volume: 18, Issue:1

    Topics: Aged; Attention; Carbamates; Disease Progression; Double-Blind Method; Female; Hallucinations; Humans; Lewy Body Disease; Male; Neuroprotective Agents; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Prospective Studies; Reaction Time; Risk Factors; Rivastigmine

2004
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Cholinesterase Inhibitors; Dementia; Double-Blind Method; Female; Follow-Up Studies; Hallucinations; Humans; Male; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome

2006
Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:6

    Topics: Aged; Carbamates; Caregivers; Cognition Disorders; Female; Follow-Up Studies; Hallucinations; Humans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Psychotic Disorders; Rivastigmine; Stress, Psychological; Treatment Outcome

2001

Other Studies

10 other study(ies) available for rivastigmine and Hallucination of Body Sensation

ArticleYear
Acute treatment of psychotic symptoms in a newly diagnosed Lewy body dementia patient with an accelerated titration schedule of rivastigmine and de-escalation of antipsychotics.
    BMJ case reports, 2019, Sep-04, Volume: 12, Issue:9

    Topics: Aged; Antipsychotic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Hallucinations; Humans; Lewy Body Disease; Male; Psychotic Disorders; Quetiapine Fumarate; Rivastigmine

2019
[Rivastigmine as treatment for flashbacks and REM sleep problems in an older patient].
    Tijdschrift voor psychiatrie, 2021, Volume: 63, Issue:1

    Topics: Dreams; Female; Hallucinations; Humans; Incest; Middle Aged; Panic Disorder; Rivastigmine; Sleep Wake Disorders; Sleep, REM; Treatment Outcome

2021
The transition from vivid dreams over floccillations and visual hallucinations to complete delirium in a geriatric patient at the dawn of Alzheimer's dementia: beneficial role of rivastigmine.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2019, Volume: 19, Issue:4

    Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Delirium; Disease Progression; Hallucinations; Humans; Male; Rivastigmine

2019
Therapeutic Effects of Rivastigmine and Alfa-Lipoic Acid Combination in the Charles Bonnet Syndrome: Electroencephalography Correlates.
    Current clinical pharmacology, 2016, Volume: 11, Issue:4

    Topics: Aged; Antioxidants; Case-Control Studies; Cholinesterase Inhibitors; Drug Therapy, Combination; Electroencephalography; Female; Hallucinations; Humans; Male; Middle Aged; Rivastigmine; Syndrome; Thioctic Acid; Treatment Outcome; Vision Disorders

2016
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report.
    BMC psychiatry, 2010, Sep-07, Volume: 10

    Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Drug Resistance; Female; Hallucinations; Humans; Phenylcarbamates; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

2010
Hallucinations treated with rivastigmine in Creutzfeldt-Jakob disease.
    Fundamental & clinical pharmacology, 2012, Volume: 26, Issue:2

    Topics: Aged; Cholinesterase Inhibitors; Creutzfeldt-Jakob Syndrome; Female; Hallucinations; Humans; Lewy Body Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome

2012
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
    Current medical research and opinion, 2002, Volume: 18, Issue:5

    Topics: Aged; Carbamates; Cholinesterase Inhibitors; Dementia; Female; Hallucinations; Humans; Male; Parkinson Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome

2002
[Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Fortschritte der Neurologie-Psychiatrie, 2003, Volume: 71, Issue:4

    Topics: Affective Disorders, Psychotic; Aged; Aged, 80 and over; Alzheimer Disease; Anxiety Disorders; Carbamates; Cholinesterase Inhibitors; Cognition; Disease Progression; Female; Hallucinations; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine

2003
A case study in the treatment of dementia with Lewy bodies.
    Acta psychiatrica Scandinavica, 2004, Volume: 110, Issue:1

    Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galantamine; Hallucinations; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Psychomotor Agitation; Rivastigmine; Social Behavior

2004
[Rivastigmine as adjunctive therapy in the therapeutic dilemma for the treatment of hallucinations due to Parkinson disease].
    Tijdschrift voor gerontologie en geriatrie, 2006, Volume: 37, Issue:3

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dose-Response Relationship, Drug; Female; Hallucinations; Humans; Male; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome

2006